🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

449 results for “Sun” Clear

  1. rhTPO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Previously Treated Primary Immune Thrombocytopenia

    approved small molecule completed

    1 trial

  2. Benazepril

    Sun Yat-sen University

    Renal Function Disorder

    small molecule completed

    1 trial

  3. Experimental

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Cognitive Health

    other completed

    1 trial

  4. Lidocaine IV

    Samsung Bioepis NL B.V.

    Colorectal Cancer

    small molecule completed

    1 trial

  5. MINGO

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    X-Linked Dystonia Parkinsonism

    other completed

    1 trial

  6. POHIM-RT

    Samsung Bioepis NL B.V.

    Cervix Cancer

    other active

    1 trial

  7. PROGRAM

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Obesity

    other completed

    1 trial

  8. Paclitaxel oral solution plus Subcutaneous Pertuzumab/Trastuzumab

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Breast Cancers

    small molecule active

    1 trial

  9. Placebo (for Motilitone)

    Samsung Bioepis NL B.V.

    Dyspepsia

    small molecule completed

    1 trial

  10. Power Line Program

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Metabolic Health

    other completed

    1 trial

  11. Probiotics

    Sun Yat-sen University

    Cardiometabolic Risk Factors

    other completed

    1 trial

  12. Redefine

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Obesity & Overweight

    other active

    1 trial

  13. Routine IOP-lowering medications

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    Open Angle Glaucoma

    small molecule active

    1 trial

  14. SSRI treated group

    Samsung Bioepis NL B.V.

    Depression

    small molecule active

    2 trials

  15. Terlipressin

    Sun Yat-sen University

    Septic Shock

    small molecule active

    1 trial

  16. araboxylan

    Sun Yat-sen University

    Subjects With Hyperuricemia

    other active

    1 trial

  17. sunitinib or pazopanib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Renal Cell Carcinoma

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources